BGNE (BeiGene, Ltd.) Pangali Forward P/E

Simbol resmi perusahaan BeiGene (BGNE)

The implementation of automated bio-screening systems accelerates drug discovery, which impacts the expected price-to-earnings multiple of BeiGene, Ltd. (BGNE). The value of 39.60 captures the magnitude of this parameter. Aggressive market expansion and patent protection are critical in the struggle against global behemoths. Meanwhile, strategic alliances with Western leaders create synergy, stimulating mergers and acquisitions within the structure of BeiGene, Ltd. (BGNE).

BeiGene - Pangali Forward P/E BGNE (periode 04.07.2022 - 16.11.2026)

Ringkesan rincian data analitis BeiGene, Ltd. (BGNE)

- rega saiki lan proyeksi nilai saham:
Analisis umum perusahaan:beigene.com
Produk merek BeiGene Ltd

For BeiGene, Ltd., which monetizes a patent-protected portfolio of oncology drugs, the company's forward P/E ratio serves as an indicator of the market valuation of future cash flows. This metric compares the current market value of the business with projected net income, allowing investors to identify whether the asset is overbought or possesses growth potential amid expanding global sales through an analysis of the chart.

Pesaing BeiGene, Ltd. (BGNE)

Pangali Forward P/E ONC|HALO (Halozyme Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (revmed.com)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Bio (BCAX) - Rega marang bathi mangsa ngarep|Personalis Corp - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Systems, Inc. DCTH|Prakiraan rega marang bathi YMAB (Y-mAbs Corp)|Pangali Forward P/E Aura Bio (AURA)|Pangali Forward P/E CADL (Candel Therapeutics Inc.)|ARAY - Prakiraan rega marang bathi|SLS - Rega marang bathi mangsa ngarep|Actuate Therapeutics - Rasio kapitalisasi marang bathi mangsa ngarep|CTOR: Pangali Forward P/E|TuHURA (HURA) - Pangali Forward P/E|TARA (Protara Therapeutics Inc) - Pangali Forward P/E|FATE: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E WHWK|TCRX (TScan) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Champions Oncology, Inc. CSBR|XBIT - Prakiraan rega marang bathi|CEL-SCI - Pangali Forward P/E|OSTX - Pangali Forward P/E|Radiopharm Theranostics Limited (RADX) - Rega marang bathi mangsa ngarep|ARTV - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi ANL|Rega marang bathi mangsa ngarep VERU|Pangali Forward P/E TPST|XLO: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E RENB (Renovaro Inc.)|Mural Bio (MURA) - Rasio prakiraan rega marang bathi|Kairos Pharma Ltd - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake OKUR|CytoMed Therapeutics Limited (GDTC) - Rega marang bathi mangsa ngarep|CRIS - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi APLM|Tharimmune (THAR) - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi ADVB (Advanced Biomed Inc.)|Genprex - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E CLDI (Calidi Biotherapeutics, Inc.)|SBFM - Prakiraan rega marang bathi|Xenetic Bio - Pangali Forward P/E|SLRX - Pangali Forward P/E|PPBT: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep AONC|Prakiraan rega marang bathi CKPT|Rega marang bathi mangsa ngarep ELEV|Pangali Forward P/E ICAD|Pangali Forward P/E Ikena Oncology Inc. (IKNA)|Pangali Forward P/E NTBL (Notable Labs Ltd)|Kapitalisasi marang proyeksi bathi Viracta Therapeutics (VIRX)|MOR: Prakiraan rega marang bathi|NAYA (NAYA Bio) - Rasio rega marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E